Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

2.130
-0.015-0.70%
Volume:34.01M
Turnover:72.75M
Market Cap:8.51B
PE:11.51
High:2.195
Open:2.145
Low:2.095
Close:2.145
52wk High:3.940
52wk Low:1.730
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:0.74
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.185
ROE:4.14%
ROA:2.44%
PB:0.45
PE(LYR):11.51
PS:1.16

Loading ...

Luye Pharma H1 2026: Revenue Drops 5.6 % to RMB 3.00 B, Net Profit Climbs 6.5 % on Lower Costs; CNS Therapies Lead Growth

Bulletin Express
·
Yesterday

Shandong Boan Biotech Files HKEX Next-Day Return Disclosing Share Buyback at HKD 3.74 Each

Reuters
·
Aug 28

LUYE PHARMA: UBS Group AG Disposes of Shares, Long Position Falls to 12.98%

HK Disclosure
·
Aug 28

Shandong Boan Biotech Enters RMB 75 Million Sale-and-Leaseback Deal with Industrial Bank Financial Leasing

Reuters
·
Aug 27

Luye Pharma's Vaccine for Cervical Precancerous Lesions to Enter Phase II Trial

MT Newswires Live
·
Aug 21

Luye Pharma Sets 29 Aug 2026 Board Meeting to Approve 1H 2026 Results and Review Interim Dividend

Bulletin Express
·
Aug 17

Luye Pharma Schedules Board Meeting to Review Interim Results, Weigh Dividend

Reuters
·
Aug 17

Shandong Boan Biotech Completes China Phase Ia Trial of Ba1302 CD228-Targeted ADC

Reuters
·
Aug 14

Shandong Boan Biotech Schedules Board Meeting on Interim Results, Dividend Review

Reuters
·
Aug 14

Luye Pharma Completes US Bridging Trial for Neurological Drug Candidate

MT Newswires Live
·
Aug 06

Luye Pharma completes U.S. bridging trial for VMAT2/Sigma-1R dual-acting drug LY03015

Bulletin Express
·
Aug 05

Shandong Boan Files Brazil Marketing Application for Ba9101 Aflibercept Biosimilar with Anvisa

Reuters
·
Aug 05

Movement Alert|Luye Pharma Declines 5.41% in Regular Trading, Trading at HK$2.09

Market Focus
·
Jul 17

Movement Alert|Luye Pharma Rises 6.45% in Regular Trading, Convertible Bond Redemption and Positive Clinical Data Drive Three-Day Rally

Market Focus
·
Jul 15

Movement Alert|Luye Pharma Rises 5.29% in Regular Trading, Convertible Bond Redemption and Clinical Progress Fuel Rally

Market Focus
·
Jul 14

Movement Alert|Luye Pharma Rises 5.73% in Regular Trading, Multiple Catalysts Including Bond Redemption and Clinical Milestones Boost Sentiment

Market Focus
·
Jul 13

Shandong Boan Says China CDE Accepts IND Filing for Ba1203 Masked Anti-pd-1/il-2 Fusion Protein

Reuters
·
Jul 08

Luye Pharma Completes Early Redemption of $180 Million Convertible Bonds

MT Newswires Live
·
Jul 07

LUYE PHARMA Successfully Completes Early Redemption of Outstanding US$180 Million Convertible Notes Due 2028

Stock News
·
Jul 06

Luye Pharma Completes Early Redemption of US$180.00 Million 6.25% Convertible Bonds

Bulletin Express
·
Jul 06